Evidence-Based Hematologic Malignancy: Therapeutic Advances for Advanced Practice Providers and Nurses 2017
Course Directors: Winston Tan, M.D.; Asher Chanan-Khan, M.D.; Nicole Gannon, P.A.-C.; Victoria Alegria, A.R.N.P.
This course gives treatment updates in hematologic malignancies with a focus on the needs of PAs, ARNPs, and hematology/oncology nurses. The topics covered will include leukemia, myeloma, multiple myeloma, bone marrow transplant, toxicity, lymphoma, and challenging cases in hematologic malignancies. There will be a unique opportunity for discussion with world-renowned cancer specialists.
Registration Fee: $175.00
Additional Information
Faculty
Lodging and Accommodation
Credit
Exhibitor Inquiry (PDF)
Program Schedule (PDF)
Course Brochure (PDF)
Exhibit Opportunity
This course offers the unique opportunity for commercial companies to interact with health care providers and highlight their products and services. If you are interested in exhibiting at this course, please complete the attached exhibit forms and submit to Florida Exhibits.
Learning Objectives
Upon conclusion of this program, participants should be able to:
- Define the major indications for therapy for each hematologic malignancy.
- Describe the appropriate molecular basis for therapy of hematologic malignancies.
- Demonstrate awareness of the common toxicities with these novel therapies
- Select the best approach to optimize management of these toxicities
Attendance at this Mayo course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course.
Contact us
Email;cme-jax@mayo.edu
Phone: 800-462-9633
ATTENTION: Please login or create an account to unlock and register below.
Available Credit
- 7.00 AMA PRA Category 1 Credit™
- 7.00 AOA